What adjustments should be made to a patient's basal insulin regimen who is currently taking 22 units of prandial insulin three times a day with Lantus (insulin glargine) twice daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Adjusting Basal Insulin in Patients Already on Prandial Insulin

For a patient taking 22 units of prandial insulin three times daily (66 units total) with Lantus twice daily, you should consolidate to once-daily Lantus dosing and systematically titrate upward by 4 units every 3 days until fasting glucose reaches 80-130 mg/dL, while maintaining the current prandial insulin doses. 1

Understanding the Current Regimen

Your patient is on a basal-bolus regimen with:

  • Prandial coverage: 22 units TID = 66 units/day of rapid-acting insulin
  • Basal coverage: Lantus twice daily (dose not specified)

The twice-daily Lantus dosing suggests either inadequate 24-hour coverage with once-daily administration or a historical prescribing pattern that may not be optimal. 2

Recommended Basal Insulin Adjustment Strategy

Step 1: Consolidate Lantus to Once-Daily Dosing

Most patients can be managed effectively with once-daily Lantus administration. 1, 2 The twice-daily dosing is typically only necessary in specific situations such as:

  • Inadequate 24-hour coverage with once-daily dosing
  • Persistent nocturnal hypoglycemia with morning hyperglycemia
  • Type 1 diabetes with high glycemic variability 2

Calculate the total current daily Lantus dose and administer it once daily at the same time each day (typically at bedtime or with the evening meal). 1, 3

Step 2: Titrate Basal Insulin Based on Fasting Glucose

Use this evidence-based titration algorithm: 1, 2

  • If fasting glucose ≥180 mg/dL: Increase Lantus by 4 units every 3 days
  • If fasting glucose 140-179 mg/dL: Increase Lantus by 2 units every 3 days
  • Target: Fasting plasma glucose 80-130 mg/dL
  • If hypoglycemia occurs: Reduce dose by 10-20% immediately 1

Step 3: Monitor for Overbasalization

Critical threshold to watch: When basal insulin exceeds 0.5 units/kg/day, you should stop escalating basal insulin and instead optimize prandial coverage or add adjunctive therapy. 1

Clinical signals of overbasalization include: 1, 2

  • Basal dose >0.5 units/kg/day
  • Bedtime-to-morning glucose differential ≥50 mg/dL
  • Hypoglycemia (aware or unaware)
  • High glucose variability

Managing the Prandial Insulin Component

Current Prandial Dosing Assessment

With 22 units TID (66 units/day prandial), this patient has substantial prandial insulin requirements. The prandial insulin should be maintained at current doses initially while you optimize basal coverage. 1

Titrating Prandial Insulin

Once basal insulin is optimized (fasting glucose 80-130 mg/dL), adjust prandial doses based on postprandial glucose readings: 1, 2

  • Increase by 1-2 units or 10-15% every 3 days based on 2-hour postprandial glucose
  • Target postprandial glucose <180 mg/dL
  • Adjust each meal's dose independently based on that meal's postprandial readings

Foundation Therapy Considerations

Ensure the patient remains on metformin unless contraindicated, as it should be continued even when intensifying insulin therapy. 1, 2 Metformin reduces total insulin requirements and provides complementary glucose-lowering effects. 2

Consider adding a GLP-1 receptor agonist if not already prescribed, especially if the patient has:

  • Cardiovascular disease (use agent with proven CVD benefit)
  • Significant weight gain concerns
  • Difficulty achieving A1C targets despite optimized insulin 1

Monitoring Requirements

Daily fasting blood glucose monitoring is essential during titration. 1, 2 The patient should also check:

  • Pre-meal glucose before each prandial insulin dose
  • 2-hour postprandial glucose to guide prandial insulin adjustments
  • Bedtime glucose to assess overnight basal coverage 2

Reassess adequacy of insulin doses at every clinical visit, looking specifically for signs of overbasalization. 1

Common Pitfalls to Avoid

Do not continue escalating basal insulin beyond 0.5-1.0 units/kg/day without addressing postprandial hyperglycemia, as this leads to overbasalization with increased hypoglycemia risk and suboptimal control. 1, 2

Do not adjust basal insulin based on postprandial glucose readings. Basal insulin addresses fasting and between-meal glucose levels, not postprandial excursions. 2 If postprandial glucose remains elevated despite optimized basal insulin, adjust the corresponding prandial dose instead.

Do not delay dose adjustments. Titrate systematically every 3 days based on glucose patterns rather than waiting weeks between changes. 1, 2

Avoid "stacking" correction doses by ensuring adequate time between correction insulin administrations, as insulin from the previous dose may still be active. 2

Special Considerations

If the patient is on high-dose insulin (≥0.6 units/kg/day total) and experiences hypoglycemia, reduce the total daily dose by 20% immediately. 2

For patients with renal impairment, age >65 years, or poor oral intake, use more conservative dosing (0.1-0.25 units/kg/day for basal insulin) to prevent hypoglycemia. 2

Patient education must include: 2

  • Recognition and treatment of hypoglycemia (treat with 15 grams fast-acting carbohydrate at glucose ≤70 mg/dL)
  • Proper insulin injection technique and site rotation
  • Self-monitoring of blood glucose
  • "Sick day" management rules
  • Insulin storage and handling

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.